Privi Speciality Chemicals Limited (PRIVISCL) Fair Value & Analysis
Basic Materials · IN · Market cap ₹144B
Fair value as of: Jul 3, 2026
From 26 valuation models · updated today
Share price +13.5% over the past month.
Price vs Fair Value (12 months)
12‑month range ₹2,213 – ₹3,751 · fair‑value band ₹794.96 – ₹3,162 · the ₹3,695 price screens above the ₹1,411 fair value. As of Jul 3, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Privi Speciality Chemicals Limited (PRIVISCL) currently trades at ₹3,695, while our model-based Fair Value estimate is ₹1,411 — implying the stock looks roughly 61.8% overvalued today. We read business quality at 66/100 (solid quality), in the Basic Materials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
Over the trailing twelve months, Privi Speciality Chemicals Limited generated revenue of ₹25.6B at a net margin of 12.8%. Revenue grew 17.6% year over year. It earns a return on equity of 24.8%. Net debt stands at ₹9.5B. Fundamentals as of Jul 3, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 3, 2026. TTM = trailing twelve months.
About the company
Privi Speciality Chemicals Limited engages in the manufacture, supply, and export of aroma and fragrance chemicals in India, North America, Asia, the Middle East, Africa, Europe, South America, and the United Kingdom. It offers a range of aroma chemicals, including alpha damascone, alpha ionone, alpha terpenyl acetate, amber fleur, amber gamma, beta iso damascol, BI perfumery grade, BI technical grade, carene-60 and carene-90, carvacrol, cedar ketol, citronellal, citronellol, citronellyl acetate, citronellyl nitrile, dipentene, double distilled turpentine oil, dihydro myrcenol, dihydromyrcene, galaxmusk, gamma methyl ionone, gamma terpenyl acetate, geraniol, geranyl acetate, Indian sandal core, ionone, iso boronyl acetate, isobornyl cyclohexanol, l-limonene, methyl ionone, nerol, neryl acetate, nimberol, OTBCHA, pine oil, prionyl, PTCBH, PTBCHA, rose oxide, sandal fleur, terpeniol alpha, terpeniol gamma, terpeniol BP grade, terpinolene, tetrahydroflorol, tetrahydrogeraniol, …
Revenue & earnings trend
FY2022 – FY2026 · reported fiscal years
Privi Speciality Chemicals Limited reported revenue of ₹25.6B in FY2026 versus ₹14.0B in FY2022, a compound +16.3%/yr. Reported net income was ₹3.3B in FY2026, compounding +35.4%/yr from FY2022.
Is PRIVISCL fairly valued? → Check now
Similar stocks
6 more Specialty Chemicals stocks, each showing price versus our Fair Value estimate (as of Jul 3, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Linde plc LIN | $507.90 | $142.21 | -72% |
| L'Air Liquide S.A AIQUY | $37.93 | $15.46 | -59% |
| Air Products and Chemicals, Inc A1PD34 | R$360.05 | R$108.63 | -70% |
| Intercontinental Exchange, Inc I1CE34 | R$367.00 | R$311.38 | -15% |
| Wanhua Chemical Group 600309 | ¥74.30 | ¥68.03 | -8% |
| Asian Paints Limited ASIANPAINT | ₹2,715 | ₹655.71 | -76% |
Explore undervalued stocks
More undervalued Basic Materials stocks →
Frequently asked questions
Is Privi Speciality Chemicals Limited (PRIVISCL) undervalued?
What is the fair value of PRIVISCL?
What is the quality score of PRIVISCL?
What is the revenue of Privi Speciality Chemicals Limited (PRIVISCL)?
What is the net profit margin of PRIVISCL?
Does Privi Speciality Chemicals Limited pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.